Showing 441-450 of 534 results for "".
- The Maze of Vision Loss and Depression in Older Adultshttps://modernod.com/news/the-maze-of-vision-loss-and-depression-in-older-adults/2476619/“The association between vision loss and depression is a complex conundrum,” Alan R. Morse, JD, PhD, President and CEO of Lighthouse Guild, said in a commentary on the challenges of vision loss and depression in older adults, published today in JAMA O
- I-MED Pharma USA Gains Exclusive Distribution Rights for ESW Vision’s E>Eye and Tearcheck in the United Stateshttps://modernod.com/news/i-med-pharma-usa-gains-exclusive-distribution-rights-for-esw-visions-eeye-and-tearcheck-in-the-united-states/2480505/I-MED Pharma has announced the expansion of their strategic partnership with ESW Vision in France to be their exclusive distributor in the United States. Through I-MED Pharma USA, two dry eye devices will be available directly to all eye care professionals across the country. E>Eye i
- Compulink Launches E-Commerce Solution for its All-in-One Optometry EHR at Vision Expo Westhttps://modernod.com/news/compulink-launches-e-commerce-solution-for-its-all-in-one-optometry-ehr-at-vision-expo-west/2476895/Compulink Healthcare Solutions will officially unveil its MyEyeStore e-commerce solution at Vision Expo West from September 19-21, 2019 in Las Vegas. MyEyeStore allows eye care practices to offer their patients the ability to order contact lenses and other recommended products directly fro
- New Chair, Members Named to Eversight Board of Directorshttps://modernod.com/news/new-chair-members-named-to-eversight-board-of-directors/2477217/Eversight announced that two new members and a new chair have been named to its Board of Directors, effective Jan. 1, 2020. Joining the Eversight Board of Directors are Carolyn Welsh, Vice President & Chief Clinical Officer, NJ Sharing Network; and Mahmoud N. Ghazzi, MD, PhD, MPH, an e
- Oyster Point Pharma Expands Executive Leadership Team to Support Commercialization of Tyrvaya Nasal Sprayhttps://modernod.com/news/oyster-point-pharma-announces-expansion-of-executive-leadership-team-to-support-commercialization-of-tyrvaya-nasal-spray/2480475/Oyster Point Pharma announced the promotion of Barry Rosenfeld, JD, as General Counsel; and Raegan A. McClain, JD, LLM, CCEP, as Chief Compliance Officer, both of whom will join the executive leadership team. “We are thrilled to expand our executive
- Medicare Sticks With E/M Pay Plan Over Some Groups’ Objectionshttps://modernod.com/news/medicare-sticks-with-e-m-pay-plan-over-some-groups-objections/2478136/The Trump administration is sticking with a plan to boost certain Medicare pay for many primary care and other specialties focused heavily on office visits while lowering that for other groups to balance these increased costs, according to a Medscape
- Study Compares the Accuracy of Subjective Refraction Using a Vmax Vision’s VASR vs. Traditional Refractionhttps://modernod.com/news/study-compares-the-accuracy-of-subjective-refraction-using-a-vmax-visions-vasr-vs-traditional-refraction/2480157/A comparison study reported at ARVO 2018, conducted by Drs. Christopher Lievens, Christina Newman, Alan Kabat, and optometry student Jacob Weber at the Southern College of Optometry (SCO), included 50 healthy subjects
- Ora Unveils Ophthalmic Research Technologies at ARVO 2022https://modernod.com/news/ora-unveils-ophthalmic-research-technologies-at-arvo-2022/2480833/From advancements in retinal and dry e
- ViaLase and the John A. Moran Eye Center Partner to Accelerate Glaucoma Research and Innovationhttps://modernod.com/news/vialase-and-the-john-a-moran-eye-center-announce-research-partnership-to-accelerate-glaucoma-research-and-innovation/2482573/ViaLase announced a research partnership with the John A. Moran Eye Center at the University of Utah, home to the Alan S. Crandall Center for Glaucoma Innovation. The collaboration will explore aqueous outflow dynamics of ViaLase’s ViaLase laser procedure, utilizing Moran’s iPerf
- Ocuphire Announces Appointment of Jay S. Pepose, MD, PhD, to Its Board of Directorshttps://modernod.com/news/ocuphire-announces-appointment-of-jay-s-pepose-md-phd-to-its-board-of-directors/2479272/Ocuphire Pharma announced the appointment of Jay S. Pepose, MD, PhD, to its Board of Directors. Concurrent to Dr. Pepose’s appointment at Ocuphire’s annual shareholder meeting on June 7, Alan Meyer, MBA, retired from his role on the Board of Directors, having served since April 2018. “We a